Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXTBiotechnology
+$0.46 today
- Market cap
- $89.11M
- Beta
- 1.05
- P/E (TTM)
- -11.1
- EPS (TTM)
- -$0.67
Volume 0.61M
Average 0.12M
LIXT Other Non-Cash Items
Other non-cash adjustments that reconcile net income to operating cash flow.
Lixte Biotechnology Holdings, Inc.NASDAQ: LIXT
Other Non-Cash Items · Q1 FY2026 · quarter ended Mar 2026
Other non-cash items outflow grows to $194.2K
Q1 FY2026 other non-cash items was $194.2K, compared with $0 a year earlier. Trailing-twelve-month other non-cash items was $1.16M.
Context
- Other non-cash items increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly other non-cash items holds near $194.2K or moves back toward the trailing-twelve-month quarterly average of $290.07K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Other Non-Cash Items history
USD · from the cash flow
- Latest · FY2025
- 966.09K USD
- Year-over-year change
- —
| Period | Period end | Other Non-Cash Items | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 966.09K | — |
| FY2024 | 2024-12-31 | 0 | -100.0% |
| FY2023 | 2023-12-31 | 773.2K | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Non-Cash Items vs competitors
How LIXT compares with its peers on the latest reported figures
- LIXT's LTM Mar 2026 other non-cash items of $1.16M is the smallest of the 2 companies compared; the peer median is $4.34M.
- Its year-over-year change of +1388.0% is the highest of 2, against a peer median of +100.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.34M | +100.3% | +68.7% | — | |
| LTM Mar 2026 | $1.16M | +1388.0% | — | — | |
| Peer median (excluding LIXT) | $4.34M | +100.3% | +68.7% | — | |
Competitors are the stored peer set for LIXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXT
Intrinsic Alpha fair value
Locked
Current Price
$7.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.